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Children with medical complexity (CMC) 
make up approximately 0.5 percent of 
all U.S. children but account for almost 
one-third of all health care spending for 
children (about $100 billion).1 Additionally, 
in children’s hospitals, CMC account for 
more than half of hospital costs for all 
admissions and 85 percent of the costs for 
30-day unplanned hospital readmissions. 
The complicated and multifaceted medical 
needs of CMC require services from different 
specialties and, frequently, from different 
states. As a result, medical care for CMC is 
often fragmented. Such fragmented care 
is problematic—though CMC depend on 
comprehensive care, they have to navigate 
a health care system that struggles to 
effectively coordinate health care services. 
This lack of coordination likely contributes 
to the high rates of adverse events (such 
as medical errors) that CMC experience 
compared to all other groups of children. 
The Advancing Care for Exceptional Kids Act 
of 2015 (ACE Kids Act) proposes a national 
database in an effort to ameliorate this 
issue by providing a centralized source of 
information on CMC. This database would 
draw on state-level databases to create 
a single source of information to ensure 
that physicians would be able to provide 
care based on meaningful, evidence-based 
results. The ACE Kids Act states “Such data 
[on care for CMC] shall be reported in a 
standardized format and made available 
to the public for purposes of establishing a 
national database on such claims.”2 
 A national database sounds appealing 
and promising for improvements in research 
and care for CMC. It is positioned to optimize 
care coordination for CMC by holding the 
children’s medical information in one 
central location that their numerous care 
providers can access. It would likely make 
tracking outcomes for CMC easier, allowing 
for best practices and improvements in care 
efficiency and efficacy. The existence of a 
national database would help to provide a 
more coordinated delivery of care system 
for CMC patients. 
 Although a national database for CMC 
is an enticing concept due to the potential 
improvements in research and medical 
care, there are ethical implications that 
make it more complicated. How might 
storing these children’s medical records 
in a national database affect their lives 
and the lives of their families? Medical 
records that are widely available can be 
problematic, because there is a potential 
for discrimination. The Genetic Information 
Nondiscrimination Act of 2008 (GINA) 
protects Americans from discrimination by 
health insurance providers and employers 
based on genetic information.3 Regarding 
health insurance, it specifically prohibits 
health insurance issuers from using 
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within the statute’s definition of “genetic 
information.” For instance, GINA would 
likely not provide protection for conditions 
that have already fully manifested. On 
the other hand, it is possible that medical 
information in the database could be 
considered family medical history and 
could be protected under GINA, but this 
is not guaranteed. Thus, there are risks 
associated with a national database
for CMC that are not overcome by the 
potential benefit of improving care 
coordination. The risks specifically lie in the 
scope of the information protected, and
that of protections afforded to patients and 
their families. 
 A national database for CMC has been 
lauded as an opportunity for researchers 
to improve treatments, families to receive 
coordinated care, and physicians to provide 
higher-quality care. However, the potential 
for discrimination against CMC and their 
families related to making their health 
information public creates concerns about 
the potential impact of passing the ACE
Kids Act.
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genetic information to determine eligibility, 
coverage, underwriting, or premiums. 
This includes information regarding 
family members. Unfortunately, GINA 
only protects an individual with a genetic 
predisposition for the disease, but not 
an individual actively suffering from said 
disease.4 As such, if a child with muscular 
dystrophy is listed in a national database, 
the employer of the child’s parent has the 
right to use this information to determine 
the cost of the parent’s, and potentially 
even the family’s, health insurance. 
 Additionally, GINA only prohibits 
genetic discrimination in the realms of 
health insurance and employment and 
fails to preclude discrimination based 
on conspicuous symptoms, or in other 
areas such as life insurance, disability 
insurance, and long-term care insurance. 
The American Medical Association (AMA) 
noted the risk of third-party access to 
genetic information in the “AMA Principles 
of Medical Ethics” by emphasizing how 
“the prospect of access to and use of such 
information [about individuals across a 
wide and growing spectrum of genetic 
variations associated with disease risk] 
by third parties who have a stake in an 
individual’s health raises ethical concerns 
about confidentiality and potentially 
inappropriate use of genetic information.”5 
Some CMC have genetic conditions that 
are passed on from their parents, and the 
presence of this information in a national 
database could have a detrimental impact 
on how the parents are viewed and treated 
by their employers. 
 Finally, GINA specifically aims to 
prohibit discrimination based on “genetic 
information,” a diverse set of data that 
goes beyond mere genetic test results. 
GINA categorizes family medical history, 
use of genetic services, and participation in 
genetic research as “genetic information.”6 
For CMC, a national database containing 
medical information may not receive 
the same type of protection. Although 
many of these children have genetic 
conditions, protection under GINA would 
require that all CMC health information fall 
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